Kiora Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapies for retinal disease. The company targets pathways underlying eye disease with small molecules aimed at preserving, slowing down, or restoring vision loss. Kiora operates in the biopharmaceutical sector, focusing on the development of treatments for ophthalmic conditions.
